|Title:||Therapeutic doses of plasma rich in growth factors cannot provoke cancer by means of the IGF-1 pathway or inflammation in dogs||Authors:||Vilar, Jose M.
Cerón Madrigal, José Joaquín
|UNESCO Clasification:||3109 Ciencias veterinarias
120903 Análisis de datos
|Keywords:||Plasma rich in growth factors
Insulin-like growth factor 1
CRP, et al
|Issue Date:||2017||Journal:||Journal of Applied Animal Research||Abstract:||A potential relationship between an increased risk of cancer and increased levels of serum insulin-like growth factor-1 (IGF-1), and presence of cancer and high levels of C-reactive protein (CRP) has been previously reported. This study evaluated the influence of a single intramuscular injection of plasma rich in growth factors (PRGF) on serum concentrations of IGF-1 and CRP in dogs. Two groups of eight healthy beagles were injected with two different doses of PRGF in lumbar muscles. For each treatment, IGF-1 and CRP were analysed from blood samples obtained at baseline and the following three days post injection. No differences were found when IGF-1 and CRP were compared among times in the two protocols. Local application of PRGF at clinical doses did not cause significant changes in systemic concentrations of IGF-1 or detectable inflammation.||URI:||http://hdl.handle.net/10553/37150||ISSN:||0971-2119||DOI:||10.1080/09712119.2016.1218888||Source:||Journal of Applied Animal Research[ISSN 0971-2119],v. 45, p. 490-493|
|Appears in Collections:||Artículos|
checked on May 2, 2021
checked on May 3, 2021
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.